Unity Biotechnology, Inc. (UBX)
NASDAQ: UBX · Real-Time Price · USD
1.060
+0.100 (10.41%)
At close: Apr 2, 2025, 4:00 PM
1.030
-0.030 (-2.83%)
After-hours: Apr 2, 2025, 7:50 PM EDT
Unity Biotechnology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 7.58 | 19.8 | 12.74 | 32.91 | 17.81 | Upgrade
|
| Short-Term Investments | 15.65 | 23.4 | 82.06 | 55.17 | 79.89 | Upgrade
|
| Cash & Short-Term Investments | 23.23 | 43.2 | 94.8 | 88.08 | 97.7 | Upgrade
|
| Cash Growth | -46.23% | -54.43% | 7.63% | -9.85% | -23.37% | Upgrade
|
| Other Receivables | 0.14 | 1.58 | 0.24 | - | - | Upgrade
|
| Receivables | 0.14 | 1.58 | 0.24 | - | - | Upgrade
|
| Prepaid Expenses | 0.9 | 1.83 | 1.51 | 1.88 | 3.17 | Upgrade
|
| Restricted Cash | - | - | - | 0.55 | - | Upgrade
|
| Total Current Assets | 24.27 | 46.61 | 96.54 | 90.5 | 100.87 | Upgrade
|
| Property, Plant & Equipment | 12.36 | 18.06 | 26.87 | 31.23 | 36.14 | Upgrade
|
| Long-Term Investments | - | - | - | 1.99 | 17.87 | Upgrade
|
| Other Long-Term Assets | 1.04 | 1.02 | 0.95 | 0.99 | 1.45 | Upgrade
|
| Total Assets | 37.66 | 65.69 | 124.35 | 124.71 | 156.32 | Upgrade
|
| Accounts Payable | 1 | 1.38 | 1.79 | 1.99 | 2.56 | Upgrade
|
| Accrued Expenses | 4.43 | 3 | 5.24 | 6.01 | 7.36 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 9.48 | 4.02 | - | Upgrade
|
| Current Portion of Leases | 3.83 | 3.45 | 3.1 | 4.38 | 4.52 | Upgrade
|
| Current Unearned Revenue | - | - | - | 0.22 | - | Upgrade
|
| Other Current Liabilities | - | 0.01 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Total Current Liabilities | 9.26 | 7.84 | 19.62 | 16.62 | 14.46 | Upgrade
|
| Long-Term Debt | - | - | 10.89 | 18.41 | 24.51 | Upgrade
|
| Long-Term Leases | 19.71 | 23.54 | 26.99 | 30.09 | 34.47 | Upgrade
|
| Other Long-Term Liabilities | 2.2 | 5.91 | 10.76 | 0.02 | - | Upgrade
|
| Total Liabilities | 31.17 | 37.29 | 68.27 | 65.14 | 73.44 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 516.82 | 512.77 | 500.83 | 459.64 | 422.38 | Upgrade
|
| Retained Earnings | -510.34 | -484.35 | -444.49 | -400.02 | -339.3 | Upgrade
|
| Comprehensive Income & Other | 0.02 | -0.02 | -0.25 | -0.04 | -0.21 | Upgrade
|
| Total Common Equity | 6.49 | 28.4 | 56.08 | 59.57 | 82.88 | Upgrade
|
| Shareholders' Equity | 6.49 | 28.4 | 56.08 | 59.57 | 82.88 | Upgrade
|
| Total Liabilities & Equity | 37.66 | 65.69 | 124.35 | 124.71 | 156.32 | Upgrade
|
| Total Debt | 23.54 | 26.99 | 50.46 | 56.9 | 63.5 | Upgrade
|
| Net Cash (Debt) | -0.31 | 16.21 | 44.34 | 33.17 | 52.07 | Upgrade
|
| Net Cash Growth | - | -63.44% | 33.67% | -36.30% | -60.10% | Upgrade
|
| Net Cash Per Share | -0.02 | 1.10 | 4.67 | 5.94 | 10.24 | Upgrade
|
| Filing Date Shares Outstanding | 16.87 | 16.79 | 14.34 | 6.89 | 5.47 | Upgrade
|
| Total Common Shares Outstanding | 16.87 | 16.78 | 14.22 | 6.3 | 5.33 | Upgrade
|
| Working Capital | 15.01 | 38.77 | 76.92 | 73.89 | 86.4 | Upgrade
|
| Book Value Per Share | 0.39 | 1.69 | 3.95 | 9.46 | 15.56 | Upgrade
|
| Tangible Book Value | 6.49 | 28.4 | 56.08 | 59.57 | 82.88 | Upgrade
|
| Tangible Book Value Per Share | 0.39 | 1.69 | 3.95 | 9.46 | 15.56 | Upgrade
|
| Machinery | 3.93 | 4.82 | 5.34 | 7.04 | 7.29 | Upgrade
|
| Construction In Progress | - | - | - | 0.01 | - | Upgrade
|
| Leasehold Improvements | 8.77 | 9.52 | 15.24 | 15.16 | 15.08 | Upgrade
|
Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.